Crosstalk between stem cell and spinal cord injury: pathophysiology and treatment strategies
A Shao, S Tu, J Lu, J Zhang - Stem cell research & therapy, 2019 - Springer
The injured spinal cord is difficult to repair and regenerate. Traditional treatments are not
effective. Stem cells are a type of cells that have the potential to differentiate into various …
effective. Stem cells are a type of cells that have the potential to differentiate into various …
Spinal cord injuries: how could cell therapy help?
A Badner, AM Siddiqui, MG Fehlings - Expert opinion on biological …, 2017 - Taylor & Francis
Introduction: Spinal cord injury (SCI) is a devastating condition, where regenerative failure
and cell loss lead to paralysis. The heterogeneous and time-sensitive pathophysiology has …
and cell loss lead to paralysis. The heterogeneous and time-sensitive pathophysiology has …
Genome-wide characterization of the routes to pluripotency
SMI Hussein, MC Puri, PD Tonge, M Benevento… - Nature, 2014 - nature.com
Somatic cell reprogramming to a pluripotent state continues to challenge many of our
assumptions about cellular specification, and despite major efforts, we lack a complete …
assumptions about cellular specification, and despite major efforts, we lack a complete …
Divergent reprogramming routes lead to alternative stem-cell states
PD Tonge, AJ Corso, C Monetti, SMI Hussein, MC Puri… - Nature, 2014 - nature.com
Pluripotency is defined by the ability of a cell to differentiate to the derivatives of all the three
embryonic germ layers: ectoderm, mesoderm and endoderm. Pluripotent cells can be …
embryonic germ layers: ectoderm, mesoderm and endoderm. Pluripotent cells can be …
Integrated genomic analysis of diverse induced pluripotent stem cells from the progenitor cell biology consortium
N Salomonis, PJ Dexheimer, L Omberg, R Schroll… - Stem cell reports, 2016 - cell.com
The rigorous characterization of distinct induced pluripotent stem cells (iPSC) derived from
multiple reprogramming technologies, somatic sources, and donors is required to …
multiple reprogramming technologies, somatic sources, and donors is required to …
Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells
Clinical applications of induced pluripotent stem cells (iPSCs) require development of
technologies for the production of “footprint-free”(gene integration-free) iPSCs, which avoid …
technologies for the production of “footprint-free”(gene integration-free) iPSCs, which avoid …
[HTML][HTML] Deciphering the roadmap of in vivo reprogramming toward pluripotency
D Chondronasiou, JM de Villarreal, E Melendez… - Stem Cell Reports, 2022 - cell.com
Differentiated cells can be converted into pluripotent stem cells by expressing the
transcription factors OCT4, SOX2, KLF4, and MYC (OSKM) in a process known as …
transcription factors OCT4, SOX2, KLF4, and MYC (OSKM) in a process known as …
Creating patient-specific neural cells for the in vitro study of brain disorders
As a group, we met to discuss the current challenges for creating meaningful patient-specific
in vitro models to study brain disorders. Although the convergence of findings between …
in vitro models to study brain disorders. Although the convergence of findings between …
Garlic-derived natural polysulfanes as hydrogen sulfide donors: Friend or foe?
In vitro and in vivo studies reported the anti-cancer potential of organosulfur compounds
(OSCs) as they trigger biological effects leading to cell cycle arrest with accumulation of cells …
(OSCs) as they trigger biological effects leading to cell cycle arrest with accumulation of cells …
Nuclear microRNAs in normal hemopoiesis and cancer
Since the discovery of microRNAs (miRNAs) in the early 1990s, these small molecules have
been increasingly recognized as key players in the regulation of critical biological …
been increasingly recognized as key players in the regulation of critical biological …